{"id":27395,"date":"2023-01-04T17:39:41","date_gmt":"2023-01-04T16:39:41","guid":{"rendered":"https:\/\/ppr-antibioresistance.inserm.fr\/?p=27395"},"modified":"2023-01-04T17:40:04","modified_gmt":"2023-01-04T16:40:04","slug":"online-consultation-research-and-innovation-objectives-for-the-oh-amr-partnership","status":"publish","type":"post","link":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/online-consultation-research-and-innovation-objectives-for-the-oh-amr-partnership\/","title":{"rendered":"Online Consultation: Research and Innovation Objectives for the OH AMR Partnership"},"content":{"rendered":"\n<figure class=\"wp-block-image size-large is-resized\"><img fetchpriority=\"high\" decoding=\"async\" src=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2023\/01\/image-1024x576.png\" alt=\"\" class=\"wp-image-27397\" width=\"565\" height=\"317\" srcset=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2023\/01\/image-1024x576.png 1024w, https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2023\/01\/image-300x169.png 300w, https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2023\/01\/image-768x432.png 768w, https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2023\/01\/image-1536x864.png 1536w, https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2023\/01\/image.png 1910w\" sizes=\"(max-width: 565px) 100vw, 565px\" \/><\/figure>\n\n\n\n<div style=\"height:40px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p>The One Health Antimicrobial Resistance partnership (OH AMR) has been identified by the European Commission as one of the European Partnerships of Horizon Europe. Currently, the Research and Innovation Objectives of OH AMR are under preparation, and we now invite researchers, stakeholders, scientists, policymakers, clinicians, patient groups, AMR-related organisations, and others to provide feedback on the<em>&nbsp;<\/em>elements included in the Research and Innovations Objectives.<\/p>\n\n\n\n<p>Please activate the online survey for this purpose here:&nbsp;<a href=\"https:\/\/survey.vr.se\/Survey\/818\">Survey:&nbsp;OH AMR Research and Innovation Objectives<\/a><\/p>\n\n\n\n<p class=\"has-text-align-center\"><strong>The consultation is open until 16 January 2023.<\/strong><\/p>\n\n\n\n<p>The online consultation outcome will guide the development of the final&nbsp;Research and Innovations Objectives, which will be included in&nbsp;the OH AMR Strategic Research and Innovation Agenda.<\/p>\n\n\n\n<p>The Research and Innovation Objectives have been developed through a number of consultations during 2022. The latest version of the document can be found here:&nbsp;<a href=\"https:\/\/www.jpiamr.eu\/app\/uploads\/2022\/12\/Research-and-Innovation-Objectives-of-the-OH-AMR-Partnership_v20221202.pdf\">Research and Innovation Objectives of the OH AMR Partnership (pdf, 1 MB)<\/a><\/p>\n\n\n\n<p>For questions regarding the consultation, please contact\u00a0<a rel=\"noreferrer noopener\" href=\"mailto:secretariat.jpiamr@vr.se\" target=\"_blank\">secretariat.jpiamr@vr.se<\/a>.\u00a0<\/p>\n\n\n\n<div style=\"height:41px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>About the OH AMR Partnership<\/strong><\/h2>\n\n\n\n<p>In the research framework of Horizon Europe and collaboration with the member states, the European Commission has identified 49 new European Partnerships, one of which is the \u201cOne Health Antimicrobial Resistance Partnership.\u201d&nbsp;<\/p>\n\n\n\n<p>The future One Health AMR (OH AMR) Partnership will be a joint research program co-funded by the European Commission and EU member states. The OH AMR Partnership aims to coordinate and align AMR activities and funding between countries and the European level. With a mix of EU and national public R&amp;I funding, the OH AMR partnership will develop joint calls and activities to address the objectives of the European One Health Action Plan against AMR and the WHO Global Action Plan on AMR to reduce the burden of AMR.<\/p>\n\n\n\n<p>For more information about the OH AMR Partnership, visit\u00a0<a rel=\"noreferrer noopener\" href=\"http:\/\/www.ohamr.eu\/\" target=\"_blank\">www.ohamr.eu<\/a>.\u00a0<\/p>\n\n\n\n<p>Source : <a href=\"https:\/\/www.jpiamr.eu\/open-consultation-oh-amr-research-and-innovation-objectives\/\">JPIAMR.eu<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The One Health Antimicrobial Resistance partnership (OH AMR) has been identified by the European Commission as one of the European Partnerships of Horizon Europe. Currently, the Research and Innovation Objectives of OH AMR are under preparation, and we now invite researchers, stakeholders, scientists, policymakers, clinicians, patient groups, AMR-related organisations, and others to provide feedback on [&hellip;]<\/p>\n","protected":false},"author":271,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[31],"tags":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Online Consultation: Research and Innovation Objectives for the OH AMR Partnership - French\u00a0National ANTIBIOTIC RESISTANCE Portal<\/title>\n<meta name=\"description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/online-consultation-research-and-innovation-objectives-for-the-oh-amr-partnership\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Online Consultation: Research and Innovation Objectives for the OH AMR Partnership - French\u00a0National ANTIBIOTIC RESISTANCE Portal\" \/>\n<meta property=\"og:description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/online-consultation-research-and-innovation-objectives-for-the-oh-amr-partnership\/\" \/>\n<meta property=\"og:site_name\" content=\"French\u00a0National ANTIBIOTIC RESISTANCE Portal\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-04T16:39:41+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-01-04T16:40:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2023\/01\/image-1024x576.png\" \/>\n<meta name=\"author\" content=\"Loane Serrano\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Loane Serrano\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/online-consultation-research-and-innovation-objectives-for-the-oh-amr-partnership\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/online-consultation-research-and-innovation-objectives-for-the-oh-amr-partnership\/\"},\"author\":{\"name\":\"Loane Serrano\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/7993978f184ff491165415f02259de61\"},\"headline\":\"Online Consultation: Research and Innovation Objectives for the OH AMR Partnership\",\"datePublished\":\"2023-01-04T16:39:41+00:00\",\"dateModified\":\"2023-01-04T16:40:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/online-consultation-research-and-innovation-objectives-for-the-oh-amr-partnership\/\"},\"wordCount\":320,\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/online-consultation-research-and-innovation-objectives-for-the-oh-amr-partnership\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2023\/01\/image-1024x576.png\",\"articleSection\":[\"Actualit\u00e9s\"],\"inLanguage\":\"en-GB\"},{\"@type\":[\"WebPage\",\"ItemPage\"],\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/online-consultation-research-and-innovation-objectives-for-the-oh-amr-partnership\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/online-consultation-research-and-innovation-objectives-for-the-oh-amr-partnership\/\",\"name\":\"Online Consultation: Research and Innovation Objectives for the OH AMR Partnership - French\u00a0National ANTIBIOTIC RESISTANCE Portal\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/online-consultation-research-and-innovation-objectives-for-the-oh-amr-partnership\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/online-consultation-research-and-innovation-objectives-for-the-oh-amr-partnership\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2023\/01\/image-1024x576.png\",\"datePublished\":\"2023-01-04T16:39:41+00:00\",\"dateModified\":\"2023-01-04T16:40:04+00:00\",\"description\":\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\",\"breadcrumb\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/online-consultation-research-and-innovation-objectives-for-the-oh-amr-partnership\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/online-consultation-research-and-innovation-objectives-for-the-oh-amr-partnership\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/online-consultation-research-and-innovation-objectives-for-the-oh-amr-partnership\/#primaryimage\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2023\/01\/image-1024x576.png\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2023\/01\/image-1024x576.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/online-consultation-research-and-innovation-objectives-for-the-oh-amr-partnership\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Practical info &amp; communications\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"News\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Online Consultation: Research and Innovation Objectives for the OH AMR Partnership\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\",\"name\":\"French\u00a0National ANTIBIOTIC RESISTANCE Portal\",\"description\":\"INSERM - From science to health\",\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\",\"name\":\"Inserm\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"width\":1,\"height\":1,\"caption\":\"Inserm\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/7993978f184ff491165415f02259de61\",\"name\":\"Loane Serrano\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Online Consultation: Research and Innovation Objectives for the OH AMR Partnership - French\u00a0National ANTIBIOTIC RESISTANCE Portal","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/online-consultation-research-and-innovation-objectives-for-the-oh-amr-partnership\/","og_locale":"en_GB","og_type":"article","og_title":"Online Consultation: Research and Innovation Objectives for the OH AMR Partnership - French\u00a0National ANTIBIOTIC RESISTANCE Portal","og_description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","og_url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/online-consultation-research-and-innovation-objectives-for-the-oh-amr-partnership\/","og_site_name":"French\u00a0National ANTIBIOTIC RESISTANCE Portal","article_published_time":"2023-01-04T16:39:41+00:00","article_modified_time":"2023-01-04T16:40:04+00:00","og_image":[{"url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2023\/01\/image-1024x576.png"}],"author":"Loane Serrano","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Loane Serrano","Estimated reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/online-consultation-research-and-innovation-objectives-for-the-oh-amr-partnership\/#article","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/online-consultation-research-and-innovation-objectives-for-the-oh-amr-partnership\/"},"author":{"name":"Loane Serrano","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/7993978f184ff491165415f02259de61"},"headline":"Online Consultation: Research and Innovation Objectives for the OH AMR Partnership","datePublished":"2023-01-04T16:39:41+00:00","dateModified":"2023-01-04T16:40:04+00:00","mainEntityOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/online-consultation-research-and-innovation-objectives-for-the-oh-amr-partnership\/"},"wordCount":320,"publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/online-consultation-research-and-innovation-objectives-for-the-oh-amr-partnership\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2023\/01\/image-1024x576.png","articleSection":["Actualit\u00e9s"],"inLanguage":"en-GB"},{"@type":["WebPage","ItemPage"],"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/online-consultation-research-and-innovation-objectives-for-the-oh-amr-partnership\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/online-consultation-research-and-innovation-objectives-for-the-oh-amr-partnership\/","name":"Online Consultation: Research and Innovation Objectives for the OH AMR Partnership - French\u00a0National ANTIBIOTIC RESISTANCE Portal","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/online-consultation-research-and-innovation-objectives-for-the-oh-amr-partnership\/#primaryimage"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/online-consultation-research-and-innovation-objectives-for-the-oh-amr-partnership\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2023\/01\/image-1024x576.png","datePublished":"2023-01-04T16:39:41+00:00","dateModified":"2023-01-04T16:40:04+00:00","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","breadcrumb":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/online-consultation-research-and-innovation-objectives-for-the-oh-amr-partnership\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/online-consultation-research-and-innovation-objectives-for-the-oh-amr-partnership\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/online-consultation-research-and-innovation-objectives-for-the-oh-amr-partnership\/#primaryimage","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2023\/01\/image-1024x576.png","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2023\/01\/image-1024x576.png"},{"@type":"BreadcrumbList","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/online-consultation-research-and-innovation-objectives-for-the-oh-amr-partnership\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/"},{"@type":"ListItem","position":2,"name":"Practical info &amp; communications","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/"},{"@type":"ListItem","position":3,"name":"News","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/"},{"@type":"ListItem","position":4,"name":"Online Consultation: Research and Innovation Objectives for the OH AMR Partnership"}]},{"@type":"WebSite","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/","name":"French\u00a0National ANTIBIOTIC RESISTANCE Portal","description":"INSERM - From science to health","publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization","name":"Inserm","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","width":1,"height":1,"caption":"Inserm"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/7993978f184ff491165415f02259de61","name":"Loane Serrano"}]}},"publishpress_future_action":{"enabled":false,"date":"2026-04-13 17:24:19","action":"change-status","newStatus":"private","terms":[],"taxonomy":"category"},"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts\/27395"}],"collection":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/users\/271"}],"replies":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/comments?post=27395"}],"version-history":[{"count":4,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts\/27395\/revisions"}],"predecessor-version":[{"id":27407,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts\/27395\/revisions\/27407"}],"wp:attachment":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/media?parent=27395"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/categories?post=27395"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/tags?post=27395"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}